🔎 Trials Near Me

Utama › Kanser Urogenital › Florida

Kajian klinikal Kanser Urogenital di Florida

6 kajian untuk Kanser Urogenital sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Holy Cross Hospital, Fort Lauderdale
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Florida, Gainesville
  • Mount Sinai Medical Center of Florida, Inc., Miami
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05874921

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Florida Cancer Specialists, Sarasota
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 25 Sep 2026 · NCT06800313

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Sylvester Comprehensive Cancer Center, Miami
  • Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 9 Jul 2026 · NCT07103018

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

  • Biogenix Molecular LLC, Miami
  • NovaCure Health, Miami
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Lelaki · Dikemas kini 14 Mei 2026 · NCT05413850

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.